STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 3] ReShape Lifesciences, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Venkateswarlu Nelabhotla filed an SEC Form 3 reporting his initial statement of beneficial ownership with respect to Vyome Holdings, Inc. (ticker HIND). The filing, tied to an event dated 08/15/2025, identifies him as both President & CEO and a director. The Form 3 states no securities are beneficially owned by the reporting person. The form is signed and dated 09/11/2025.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Initial ownership filing reports no securities held by the issuer's President & CEO—neutral disclosure.

The Form 3 documents an initial Section 16 filing for Vyome Holdings, Inc., naming Venkateswarlu Nelabhotla as President & CEO and director. Crucially, the filer indicates no beneficial ownership of the issuer's securities as of the reported event date. From a market-impact perspective, the disclosure itself is routine and provides transparency about insider holdings; it does not reveal transactions or holdings that would affect valuation or shareholder voting dynamics.

TL;DR: The filing fulfills Section 16 reporting requirements but contains no material ownership information.

The submission meets the regulatory requirement to disclose initial insider status and role (President & CEO; director). Reporting no beneficial ownership is notable for record-keeping but does not indicate any insider purchases, grants, or equity incentive exercises. For governance monitoring, this is a neutral data point: it documents officer/director status without disclosing equity interests or potential conflicts.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Nelabhotla Venkateswarlu

(Last) (First) (Middle)
HARVARD SQUARE,
ONE MIFFLIN PLACE, SUITE 400

(Street)
CAMBRIDGE MA 02138

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/15/2025
3. Issuer Name and Ticker or Trading Symbol
Vyome Holdings, Inc [ HIND ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Venkateswarlu Nelabhotla 09/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed by Venkateswarlu Nelabhotla disclose for Vyome Holdings (HIND)?

The Form 3 names Venkateswarlu Nelabhotla as President & CEO and director and states no securities are beneficially owned as of the event date.

What is the event date and filing/signature date on the Form 3?

The event requiring the statement is dated 08/15/2025, and the form is signed and dated 09/11/2025.

Does the Form 3 report any derivative or non-derivative securities owned by the reporting person?

No. The filing explicitly states no securities are beneficially owned, and no entries appear in Table I or Table II.

What roles does the reporting person have at the issuer according to the filing?

The filing lists the reporting person as both a Director and an Officer with the title President and CEO.

Which issuer and ticker are identified in the Form 3?

The Form 3 identifies the issuer as Vyome Holdings, Inc. with ticker HIND.
ReShape Lifesciences Inc.

NASDAQ:RSLS

RSLS Rankings

RSLS Latest News

RSLS Latest SEC Filings

RSLS Stock Data

7.64M
5.48M
10.63%
1.35%
2.19%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN CLEMENTE